What is The Haven Detox Group?
The Haven Detox Group operates at the intersection of clinical medicine and behavioral health, providing comprehensive detoxification protocols designed to address the physiological complexities of substance dependency. By prioritizing the elimination of chemical substances and the subsequent restoration of neurological homeostasis, the company has established a robust model for early-stage addiction treatment. Their market position is defined by a focus on high-acuity care, effectively bridging the gap between acute medical intervention and long-term recovery support systems. As the demand for evidence-based detoxification services rises, the company remains a critical player in the broader healthcare ecosystem, leveraging proprietary methodologies to improve patient outcomes.
How much funding has The Haven Detox Group raised?
The Haven Detox Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in The Haven Detox Group
PPP
Public-Private Partnership
What's next for The Haven Detox Group?
With the recent infusion of capital, The Haven Detox Group is well-positioned to accelerate its operational footprint and enhance its clinical service offerings. The strategic focus will likely shift toward scaling facility capacity and integrating advanced diagnostic tools to further refine their detoxification programs. By optimizing their service delivery model, the company aims to capture a larger share of the growing behavioral health market, ensuring that their evidence-based approach to reversing physical dependency remains accessible to a broader demographic. Future growth trajectories will likely involve regional expansion and the potential integration of digital health monitoring to support post-detox continuity of care.
See full The Haven Detox Group company page
